Never ever visited any rowdy’s home; will retire from politics if allegations proven: UT Khader

coastaldigest.com news network
January 22, 2018

Mangaluru, Jan 22: Dismissing the rumours about his visit to a rowdy’s home during poll campaign in his constituency as baseless and false, Food and Civil Supplies Minister U T Khader has said that he never ever visited any rowdy’s home so far and would never stoop to such a low level in future too.

Speaking at a programme here on Sunday, Mr Khader, who had earlier preferred to ignore the mudslinging, said that he would retire from politics if the allegations of his association with any rowdy are proved to be true.

“My personal and political life is an open book. People of my constituency know me very well. They have always blessed me and supported me. It’s my duty to serve them. There is no necessity for me to make friendship with any rowdy,” he clarified.

A few Kannada TV channels and newspapers had recently claimed that Target Gang leader Eliyas who was hacked to death by rival gang members last week, was a in touch with Mr Khader.

Some media went on to claim that Eliyas’ wife Farzana had stated that Mr Khader used to visit their house and hang out with her husband during election campaign.

"Just because Eliyas was seen in a picture having lunch in a wedding party where I was also present, it does not mean that I was close to him. I cannot ask somebody to go away when they come and have lunch sitting next to me in a third person’s wedding party. But if you prove that I visited a rowdy’s house I will immediately retire from politics,” he said.

Comments

Rahul
 - 
Monday, 22 Jan 2018

He is not fit for politics. He is best for acting good samaritan

Kumar
 - 
Monday, 22 Jan 2018

Good people will get blame and critisism always

Fan from Dubai
 - 
Monday, 22 Jan 2018

I request Khader bhai to retire from politics and spend time with his noble family. The people of Ullal really don’t deserve such a great leader. For them pett kammis are enough. Being a fan I really cant bear people making false allegations against a jewel like Mr Khader

Zaid
 - 
Monday, 22 Jan 2018

Farzana did not give any statement to media. She is in iddah. One munafiq BJP leader made a fake letter viral in her name for political benefits. Communal media seized the opportunity to tarnish Khader’s image.

Ullala Manja
 - 
Monday, 22 Jan 2018

Dear Khader bhai. This is a good lesson for you. Now onwards please stop attending weddings and goodangadi opening ceremonies. I know you want to be down do earth. But some jealous people want to put u down to earth. So always be careful. Especially avoid some Bearys.

wellwisher
 - 
Monday, 22 Jan 2018

Here in our city only  BJP leaders in rowdy sheet and category. So if you visited any BJP leaders or standing mp  house then please tell.

Nothing to do our point any of our youths. They are the main epicenter for rowdisim. On thier sponsorship our

youngsters are spoiled.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 26,2020

Bengaluru, Mar 26: The number of COVI D-19 cases in Karnataka spiked to 55 on Thursday after four new cases were reported. 

According to official sources, a 35-year-old man, who was a resident of Nanjanagud town in Mysuru taluk and worked in a pharma unit, tested positive for coronavirus. 

He had been quarantined in his home and efforts are being made to track down as many as seven persons, who had primary contact with 
him.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 5,2020

Bengaluru, Mar 5: Karnataka government on Thursday set aside Rs 400 crore to construct twin towers building with 25 floors here at Anand Rao Circle to facilitate all government departments to function at one place.

"To facilitate all the Government Departments to function in one building, a "Twin-Towers" building with 25 storeys will be constructed at Arland Rao Circle, Bengaluru, with an expenditure of Rs 400 crore," said Karnataka Chief Minister Yediyurappa while presenting the budget in the state Assembly.

He further said that the road cross-over facility for pedestrians other than metro commuters will be provided through 24 metro stations.

"The construction of 56 km long Outer Ring Road - Airport Metro from Central Silk Board junction to Bengaluru International Airport via K R Puram and Hebbala at an estimated cost of Rs 14,500 crore will be commenced during the year 2020-21," he said.

Rs 1,000 crore budget each have been announced for the restoration of Bengaluru roads for two years, 276 Karnataka public school for their infrastructure development.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.